Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -15.3313.5327.9013.836.98

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is -15.33 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-15.33
Mar202513.53
Mar202427.90
Mar202313.83
Mar20226.98

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2026 -15.33
Negative
Mar2025 13.53
-51.51
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹108,016.2 Cr 0.9% -3.2% -15.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics
MANKIND PHARMA ₹91,572.1 Cr -2.6% -10.6% -7.3% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

0.9%

-3.2%

-15.2%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses